Copertina

Multivalent Rhamnose‐Modified EGFR‐Targeting Nanobody Gains Enhanced Innate Fc Effector Immunity and Overcomes Cetuximab Resistance via Recruitment of Endogenous Antibodies

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Yanchun Li, Han Lin, Haofei Hong, Dan Li, Liang Gong, Jie Zhao, Zheng Wang, Zhimeng Wu
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Advanced Science
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Tumor Cell‐Specific Metabolic Labelling of Surface Sialoglycans and Post‐Click with Multivalent Rhamnose Enable Precise Immune Killing by Endogenous Antibody
di: Haofei Hong, et al.
Pubblicazione: (2024)

In Situ Self‐Assembly of Antibody‐Rhamnose Complex as a Pre‐Targeting Strategy for Enhanced Cancer Immunotherapy
di: Haofei Hong, et al.
Pubblicazione: (2024)

Chemo‐Enzymatic Functionalization of Bovine Milk Exosomes with an EGFR Nanobody for Target‐specific Drug Delivery
di: Ranran Zhang, et al.
Pubblicazione: (2024)

A Redox‐Responsive β‐Glucan‐Based Vaccine Recruiting Endogenous Antibodies to Potentiate Antifungal Immunity
di: Zhifang Zhou, et al.
Pubblicazione: (2026)

A CMTM6 Nanobody Overcomes EGFR‐TKI Resistance in Non‐Small Cell Lung Cancer
di: Lu Xia, et al.
Pubblicazione: (2025)

Multivalent Antibody‐Recruiting Molecules for Targeted Immune‐Killing of Carbonic Anhydrase IX‐Expressing Cancer Cells
di: Haixia Peng, et al.
Pubblicazione: (2026)

Multivalent Antibody‐Recruiting Molecules for Targeted Immune‐Killing of Carbonic Anhydrase IX‐Expressing Cancer Cells
di: Haixia Peng, et al.
Pubblicazione: (2026)

Polymeric Multivalent Fc Binding Peptides‐Fabricated Clinical Compounding Bispecific Antibody Potentiates Dual Immunotherapy Targeting PD1 and CTLA‐4
di: Zongyu Liu, et al.
Pubblicazione: (2024)

Synthesis of Rhamnose‐Modified Lewis‐X‐Containing Saponins
di: Oscar Javier Gamboa Marin, et al.
Pubblicazione: (2025)

Programmable Circular Multivalent Nanobody‐Targeting Chimeras (mNbTACs) for Multireceptor‐Mediated Protein Degradation and Targeted Drug Delivery
di: Shiqi Jiang, et al.
Pubblicazione: (2024)

Programmable Circular Multivalent Nanobody‐Targeting Chimeras (mNbTACs) for Multireceptor‐Mediated Protein Degradation and Targeted Drug Delivery
di: Shiqi Jiang, et al.
Pubblicazione: (2024)

Innate Immunity
Pubblicazione: (2020)

Broad‐Spectrum Engineered Multivalent Nanobodies Against SARS‐CoV‐1/2
di: Zhihong Wang, et al.
Pubblicazione: (2024)

Nanobodies Outperform Antibodies – Rapid Functionalization with Equal In Vivo Targeting Properties
di: Carina Jung, et al.
Pubblicazione: (2024)

Journal of Innate Immunity
Pubblicazione: (2019)

Heterogeneity of Innate Immunity
di: Xiaohan Yu, et al.
Pubblicazione: (2025)

Overcoming EGFR‐Mediated Dendritic Cell Dysfunction to Enhance Anti‐tumor Immunity in EGFR‐Mutant NSCLC by Precisely Targeting CD73 With pH‐responsive Nanocarriers
di: Xiaoling Shang, et al.
Pubblicazione: (2025)

Magnoliae flos Overcomes EGFR ‐ TKI Resistance in NSCLC by Enhancing EGFR Ubiquitination
di: Qing Wu, et al.
Pubblicazione: (2026)

A Dually Nanobody‐Engineered Milk‐Derived Extracellular Vesicle Nanomedicine Targeting Tumour‐Associated Macrophages and Cancer Cells for Cancer Therapy
di: Zhiang Liu, et al.
Pubblicazione: (2026)

A Self‐Assembled Protein Platform for Plug‐and‐Play Customization of Multivalent Artificial Antibodies and Antibody‐Drug Conjugates
di: Yuzhe Chen, et al.
Pubblicazione: (2025)

Adaptabodies: Retargeting a Predefined Monoclonal Antibody With Bispecific Nanobodies for Antibody Therapy
di: Andrés González‐Techera, et al.
Pubblicazione: (2025)

Senescent Factors Suppress Innate Antiviral Immunity in Aged Mice via Two Distinct Mechanisms
di: Xu Zhang, et al.
Pubblicazione: (2026)

Recognition of a Fungal Effector Potentiates Pathogen‐Associated Molecular Pattern‐Triggered Immunity in Cotton
di: Lifan Sun, et al.
Pubblicazione: (2024)

The Candidate Effector Cgmas2 Orchestrates Biphasic Infection of in Maize by Coordinating Invasive Growth and Suppressing Host Immunity.
di: Gong, Ziwen, et al.
Pubblicazione: (2026)

Nanobodies Outperform Antibodies – Rapid Functionalization with Equal In Vivo Targeting Properties (Adv. Mater. 52/2024)
di: Carina Jung, et al.
Pubblicazione: (2024)

Tetrahedral DNA Nanoframework‐Based Multivalent Aptamers Functionalized Biomimetic Hydrogel Scaffold Enhances Osteochondral Regeneration by Recruitment and Protection of Endogenous Stem Cells
di: Fei Gao, et al.
Pubblicazione: (2025)

The Unusual Role of Ribonuclease L in Innate Immunity
di: Agnes Karasik, et al.
Pubblicazione: (2024)

Balancing Stealth and Targetability: cCPP‐ and PEG‐Modified Liposomes for the Targeted Delivery of Anti‐HER2 Nanobodies
di: Giulia Pander, et al.
Pubblicazione: (2026)

Dual‐Targeting of the HER2 Cancer Receptor with an Antibody‐Directed Enzyme and a Nanobody‐Guided MMAE Prodrug Scaffold
di: Jakob Melgaard Smidt, et al.
Pubblicazione: (2024)

In Defense of Homeostasis: Innate Immunity in Cardiac Injury and Repair
di: Douglas L. Mann
Pubblicazione: (2026)

Innate Immunity in Helicobacter pylori Infection and Gastric Oncogenesis
di: Yuheng Zhang, et al.
Pubblicazione: (2025)

Bitter Taste Receptors in Bacterial Infections and Innate Immunity
di: Erin Rudolph, et al.
Pubblicazione: (2025)

Copper Homeostasis and Its Impact on Innate Immunity in Crustaceans
di: Hejia Chen, et al.
Pubblicazione: (2024)

Inside Back Cover: A Self‐Assembled Protein Platform for Plug‐and‐Play Customization of Multivalent Artificial Antibodies and Antibody‐Drug Conjugates (Angew. Chem. 40/2025)
di: Yuzhe Chen, et al.
Pubblicazione: (2025)

Differential Expression of Defensins and Other Innate Immune Effectors by Indian Isolates of Chikungunya Virus
di: Sanket Kumar Ray, et al.
Pubblicazione: (2026)

Quantitative Prediction of Human Pharmacokinetics for Fc‐Engineered Therapeutic Monoclonal Antibodies With Increased FcRn Binding Mutations After Subcutaneous Injection
di: Kenta Haraya, et al.
Pubblicazione: (2026)

Innate Immunity and Microbial Recognition in Reproduction: From Barrier Defense to Maternal–Fetal Tolerance
di: Xianlin Rao, et al.
Pubblicazione: (2026)

Nanobodies
Pubblicazione: (2005)

Zirconia Minimizes Myeloid Innate Immunity as Dental Implants: An In Silico and In Vivo Study
di: Li‐Tzu Wang, et al.
Pubblicazione: (2025)

Genetically Engineered Nanobody–Recombinant Antibody Colloidal Gold Strip for Ultrasensitive Atrazine Detection in Fruits and Vegetables
di: Jiayong Bao, et al.
Pubblicazione: (2026)